News & Updates
Search Research Content
Resource Finder at Kennedy Krieger Institute
A free resource that provides access to information and support for individuals and families living with developmental disabilities.
Evaluation of capecitabine and oxaliplatin administered prior to and then concomitant to radiotherapy in high risk locally advanced rectal cancer.
|Title||Evaluation of capecitabine and oxaliplatin administered prior to and then concomitant to radiotherapy in high risk locally advanced rectal cancer.|
|Publication Type||Journal Article|
|Year of Publication||2013|
|Authors||Gao Y-H, An X, Sun W-J, Cai J, Cai M-Y, Kong L-H, Lin J-Z, Liu G-C, Tang J-H, Wu X-J, Chen G, Pan Z-Z, Ding P-R|
|Journal||Journal of surgical oncology|
|Date Published||2013 Nov 28|
Systemic failure remains a predominant issue in locally advanced rectal cancer (LARC). A new strategy using capecitabine and oxaliplatin (XELOX regimen) administered prior to and then concomitant to radiotherapy for high risk LARC is developed in our practice. The aim of the present study was to evaluate the short-term efficacy and toxicities of this strategy.
|Alternate Journal||J Surg Oncol|